[1] [1] KAMLEKAR R K, DHIRENDRA K, GAO Y G, et al. The glycolipid transfer protein (GLTP) domain of phosphoinositol 4-phosphate adaptor protein-2 (FAPP2): structure drives preference for simple neutral glycosphingolipids［J］. Biochimica et Biophysica Acta, 2013, 1831(2): 417-427.

[2] [2] ZOU X Q, GAO Y G, RUVOLO V R, et al. Human glycolipid transfer protein gene (GLTP) expression is regulated by Sp1 and Sp3: involvement of the bioactive sphingolipid ceramide［J］. Journal of Biological Chemistry, 2011, 286(2): 1301-1311.

[3] [3] BSCHIR K. Perspectivism in current epigenetics［J］. European Journal for Philosophy of Science, 2020, 10(3): 369-398.

[4] [4] MALININA L, SIMANSHU D K, ZHAI X, et al. Sphingolipid transfer proteins defined by the GLTP-fold［J］. Quarterly Reviews of Biophysics, 2015, 48(3): 281-322.

[5] [5] OCHOA-LIZARRALDE B, GAO Y G, POPOV A N, et al. Structural analyses of 4-phosphate adaptor protein 2 yield mechanistic insightsinto sphingolipid recognitionby the glycolipid transfer protein family［J］. Journal of Biological Chemistry, 2018, 293(43): 16709-16723.

[6] [6] MATTJUS P. Specificity of the mammalian glycolipid transfer proteins［J］. Chemistry and Physics of Lipids, 2016, 194: 72-78.

[7] [7] YU J T, WEN J T, BIAO T. Integrated analysis of hub genes and pathways in esophageal carcinoma based on NCBI’s gene expression omnibus: a bioinformatics analysis［J］. Medical Science Monitor, 2020, 26: e923934.

[8] [8] LARSSON C, CORDEDDU L, SIGGENS L, et al. Restoration of KMT2C/MLL3 in human colorectal cancer cells reinforces genome-wide H3K4me1 profiles and influences cell growth and gene expression［J］. Clinical Epigenetics, 2020, 12(1): 333-339.

[9] [9] LOCAL A, HUANG H, ALBUQUERQUE C P. Identification of H3K4me1-associated proteins at mammalian enhancers［J］. Nature Genetics, 2018, 50(1): 73-82.

[10] [10] HOWE F S, FISCHL H, MURRAY S C, et al. Is H3K4me3 instructive for transcription activation［J］. Bioessays, 2017, 39(1): 1-12.

[12] [12] HUANG X, YAN J, ZHANG M. Targeting epigenetic crosstalk as a therapeutic strategy for EZH2-aberrant solid tumors［J］. Cell, 2018, 175(1): 186-199.

[15] [15] TANG Z, LI C, KANG B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses［J］. Nucleic Acids Research, 2017, 45(W1): W98-W102.

[16] [16] CERAMI E, GAO J, DOGRUSOZ U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data［J］. Cancer Discovery, 2012, 2(5): 401-404.

[17] [17] DíEZ-VILLANUEVA A, MALLONA I, PEINADO M A. Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer［J］. Epigenetics Chromatin, 2015, 8: 22.

[18] [18] KAROLCHIK D, BAERTSCH R, DIEKHANS M, et al. The UCSC genome browser database［J］. Nucleic Acids Research, 2003, 31(1): 51-54.

[19] [19] JEGGARI A, MARKS D S, LARSSON E. MiRcode: a map of putative microRNA target sites in the long non-coding transcriptome［J］. Bioinformatics, 2012, 28(15): 2062-2063.

[20] [20] VLACHOS I S, HATZIGEORGIOU A G. Functional analysis of miRNAs using the DIANA tools online suite［J］. Methods in Molecular Biology, 2017, 1517: 25-50.

[21] [21] SHANNON P, MARKIEL A, OZIER O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks［J］. Genome Research, 2003, 13(11): 2498-2504.

[22] [22] ZHOU L, LIANG X, ZHANG L, et al. MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2［J］. Oncotarget, 2016, 7(32): 51943-51954.

[23] [23] WADE S M, OHNESORGE N, MCLOUGHLIN H, et al. Dysregulated miR-125a promotes angiogenesis through enhanced glycolysis［J］. EBioMedicine, 2019, 47: 402-413.

[24] [24] HU Z, GUO J, ZHAO M, et al. Predictive values of miR-129 and miR-139 for efficacy on patients with prostate cancer after chemotherapy and prognostic correlation［J］. Oncology Letters, 2019, 18(6): 6187-6195.

[25] [25] YU D, YUE W, XUE W, et al. Effects of long non-coding RNA myocardial infarction-associated transcript on retinal neovascularization in a newborn mouse model of oxygen-induced retinopathy［J］. Neural Regeneration Research, 2021, 16(9): 1877-1881.

[26] [26] PENG H, PAN X, SU Q, et al. MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer［J］. European Review for Medical and Pharmacological Sciences, 2019, 23(19): 8332-8344.

[27] [27] CHEN X, LOU N, RUAN A, et al. MiR-224/miR-141 ratio as a novel diagnostic biomarker in renal cell carcinoma［J］. Oncology Letters, 2018, 16(2): 1666-1674.

[28] [28] SHI L, FAN B, CHEN D, et al. Human cytomegalovirus protein UL136 activates the IL-6/STAT3 signal through miR-138 and miR-34c in gastric cancer cells［J］. International Journal of Clinical Oncology, 2020, 25(11): 1936-1944.

[30] [30] SADAKIERSKA-CHUDY A. MicroRNAs: diverse mechanisms of action and their potential applications as cancer Epi-Therapeutics［J］. Biomolecules, 2020, 10(9): 1-21.